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Artificial intelligence (AI), the use
of machines to perform tasks that
typically require human intelligence,
has revolutionized industries and is set
to alter the future of healthcare. Unlike
traditional decision-making which uses
a predetermined
set of instructions,
AI utilizes data input by users to create
a decision-making algorithm. These selflearning, data-driven algorithms can
analyze large volumes of data and draw
conclusions with astounding accuracy.
Although AI may pose legitimate
concerns such as job automation
and data security1, ultimately these
tools may assist and improve human
decision-making performance, such as
in healthcare providers. In particular,
several ophthalmology studies have
already demonstrated AI’s ability to help
physicians screen, diagnose, and treat
ocular diseases2.
Dr. Ravi Goel is a comprehensive
ophthalmologist and cataract surgeon
at Wills Eye Hospital, with a specific
interest in finding ways that AI can help
ophthalmologists improve their clinical
care and treat more patients. Dr. Goel also
publishes a daily blog, Protecting Sight,
where he discusses a variety of topics
ranging from advances in cataract surgery
to medical education. One common thread
throughout his blog is the burgeoning
impact of AI on the field of ophthalmology,
such as the utility of deep learning
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algorithms for diagnosing various diseases
and the impact that improved intra-ocular
lens (IOL) power calculations will have on
patient care. We sat down with Dr. Goel
to learn more about the effects that AI will
have on the field of ophthalmology and
hear his thoughts about what the future
holds for this exciting corner of medicine.
How do you think AI will affect your
practice? What are some of the
current advantages and limitations?
“The clear advantage of AI in
ophthalmology is that it can lead us to
treatment and diagnosis earlier.”
Dr. Goel is a firm believer in the
potential of AI to improve the field of
ophthalmology. According to the World
Health Organization (WHO), 80% of visual
impairment is preventable and curable. Dr.
Goel believes that “the clear advantage
of AI in ophthalmology is that it can lead
us to treatment and diagnosis earlier.”
Guided by AI, earlier diagnosis and
treatment of retinal and anterior segment
eye conditions would vastly improve
patient outcomes3.
One of the main advantages for the use
of AI in ophthalmology is that imagingbased medical fields have amassed
enormous datasets from which AI can be
trained. The more data the artificial neural
network receives, the more accurate its
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results will be. For example, using data
from nearly 285,000 patients, AI was able
to predict a patient’s sex from their fundus
photography with an astonishing 97%
accuracy4.
Although this technology seems
promising, it is not without its limitations.
If you wanted to know the algorithm
used to predict sex based on imaging,
that insight is currently unavailable due
to what is known as the “black-box”
problem (defined inputs and outputs with
an unknown algorithm). Additionally, due
to the AI’s specialized focus on answering
one very specific question at a time, a
primary challenge that Dr. Goel cited was
the need to monitor advances in AI in other
medical and surgical subspecialties2. By
collaborating with and taking inspiration
from other specialties or industries entirely,
both physicians and their partners could
advance their respective fields.

Sight) Registry, the world’s largest specialty
clinical database. This collaboration will
allow participating entities to have larger
study sample sizes for greater statistical
power and can be used to evaluate clinical
performance metrics, improve patient
care, and develop stronger AI algorithms5.
However, Dr. Goel mentioned that some
large electronic medical record companies
like Epic have yet to contribute data to the
IRIS Registry. With time, the hope is that
such large entities will contribute to these
shared clinical databases with the goal of
improving patient care.
In addition, some of the most promising
research in AI and ophthalmology, in
Dr. Goel’s opinion, is related to diabetic
retinopathy (DR) and cataract surgery. For
DR, earlier detection and treatment can
dramatically slow disease progression6.
Notably, in August of 2020, the FDA
cleared the EyeArt autonomous AI system

How do you feel the field of
ophthalmology will change to
become more conducive to the use
of artificial intelligence in the next
5-10 years?
“The point of big data is to answer
questions we don’t even know to ask
yet.”
“The challenge for ophthalmology will
be that we have to come together and
improve the way we record data,” Dr. Goel
says. AI decision-making algorithms are
only as reliable as the data from which they
were trained. Fortunately, the American
Academy of Ophthalmology (AAO)
created the IRIS (Intelligent Research In
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for DR screening7. In cataract surgery, AI
may help improve the performance of IOL
calculation formulas8. With its potential
integration into automated refraction
devices, AI may help provide an improved
framework for IOL formula optimization
that is more accurate and customized to a
specific cataract surgeon.
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Although the possibilities of AI may
seem endless, its applications rely
on human creativity to ask novel and
meaningful questions. “The point of
big data,” Dr. Goel says, “is to answer
questions we don’t even know to ask yet.”
With increased collaboration, AI will be
poised to improve healthcare and other
fields.
Cataracts are the leading cause
of visual impairment worldwide.
Given your experience training
abroad, how do you feel AI can help
ophthalmologists exert a greater
impact on patients around the world,
especially those in lower income
countries/communities?
“In
some
other
countries,
[ophthalmologists] have to choose
which eye to treat because they don’t
have the resources to treat both eyes
for everyone.”
There are over 285 million visually
impaired people around the world, with
90% of patients living in developing
countries9. In the coming years, this
number will likely continue to grow due
to longer patient lifespans and chronic
diseases that impair vision.
With these statistics in mind, Dr. Goel
believes that one of the biggest obstacles
facing ophthalmologists worldwide is a
massive mismatch between the supply
of ophthalmologists and the demand for
treatment. “In some other countries,”
he explains, “[ophthalmologists] have to
choose which eye to treat because they
don’t have the resources to treat both
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eyes for everyone.” This disturbing reality
is corroborated by Owen O’Donnell, who
explains that one of the biggest issues
in low- and middle-income countries is
limited access to healthcare10. Dr. Goel
believes that future innovations in AI will
serve to expand the reach an individual
ophthalmologist can make, allowing them
to begin attacking this massive disparity.
He explains, “if AI can free up my time
to do surgery instead of dry eye exams,
I can be a bigger help to more patients.”
Although this will not completely address
the supply-demand disparity, he believes
that optimization of his time will allow him
to make a substantial impact on a larger
number of patients.
Various studies support this idea
by showing that there is comparable
diagnostic performance in using AI to
screen, diagnose, predict and monitor
various eye conditions on fundus
photographs and optical coherence
tomography, including DR, age-related
macular degeneration, glaucoma, and
retinopathy of prematurity (ROP)11-14. These
studies posit that if ophthalmologists can
use AI to more quickly diagnose a larger
volume of patients with eye disorders, they
will have more time to perform procedures
and actually treat patients. With this in
mind, if ophthalmologists are able to
implement some of these AI technologies
in developing countries around the world,
they will begin addressing the supplydemand disparity issue in the places that
experience the greatest disparities. In
this way, we will be able to empower the
field of ophthalmology to exert a greater
impact on communities around the world.
The future of AI in the field of
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ophthalmology is incredibly bright.
Following our conversation with Dr. Goel,
it is clear that AI may lead to improved
diagnosis, superior treatment, and
expanded access to care, with great
potential for other improvements in the
future. To continue to find ways for AI to
enhance the field of ophthalmology, it is
important for clinical staff to monitor other
fields of medicine to look for inspiration.
For example, using multiple sensors,
Stanford’s program AI-assisted care
(PAC) can sense any behavioral changes
in elderly people living alone15 and ICU
patients16, respectively, which will allow
for greater patient monitoring outside
of the clinic. Ophthalmologists may be
able to utilize a similar system to track
medication adherence or post surgical
recovery. Another potential lesson can be
taken from Beth Israel Deaconess Medical
Center, where a team of researchers
created an AI diagnostic program that
could identify cancer in pathology slides
with 92% accuracy, nearly as accurate as
a human pathologist at 96%. However,
when they combined the AI program with
the pathologist’s analysis, the diagnostic
accuracy improved to 99.5%17. Similar
technology could potentially aid ocular
oncologists with diagnosing complex rare
or cancer cases. Such remarkable results
suggest a promising future for physicians,
assisted by the power of AI, to deliver
better healthcare to even more patients.
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